Intravitreal conbercept at the end of diabetic vitrectomy for prevention of postoperative vitreous hemorrhage in proliferative diabetic retinopathy.
Phase of Trial: Phase IV
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Conbercept (Primary)
- Indications Vitreous haemorrhage
- Focus Therapeutic Use
- 20 Apr 2018 New trial record